Clinical Trial Update: Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the efficacy and safety of levofloxacin-based triple therapy for Helicobacter pylori eradication. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Levofloxacin (Levofloxacin)
• Omeprazole (Omeprazole)

Snippet

Sponsor: Deva Holding A.S. | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED